This website is not optimized for your browser version. Update to the latest Internet Explorer Version for a safer and faster web experience
2018 Neuromodulation Society of Australia and New Zealand<br/>13th Annual Scientific Meeting

2018 Neuromodulation Society of Australia and New Zealand
13th Annual Scientific MeetingNeuromodulation - Delivering on Patient Outcomes6 - 8 April 2018 | International Convention Centre, Sydney | Australia

Sponsored Sessions

Further information coming soon

Saturday 7 April 2018 - 7.30 - 8.30 am (includes breakfast)

 

Intellis with evolve…. Personalised, future proof chronic pain management

Official launch of Medtronic’s next generation platform, Intellis. Dr Marc Russo will detail first implanter experience within Australia, and outline the products significance within the pain stimulation market. Conversation will also focus upon innovative programming paradigms and the need for versatility; in specific relation to the Intellis platform.

Leading the Way: Transforming Patient Outcomes

Professor Julie Pilitsis MD, PhD is a Professor of Neurosurgery and of Neuroscience at Albany Medical College, Albany, NY, and Chair for the Department of Neuroscience and Experimental Therapeutics. She completed her neurosurgery residency at Wayne State University in Detroit, MI. During that time, she also obtained a PhD in neurophysiology and became active in both basic science and translational research. She went on to complete a fellowship in Functional Neurosurgery at Rush University Medical Center in Chicago, IL, focusing in the neurosurgical treatment of movement disorders. She returned to her alma mater Albany Medical College in 2011, joining the division of neurosurgery as an associate professor of neurosurgery and in the Center for Neuropharmacology and Neurosurgery.

 

 

Sunday 8 April 2018 - 7.30 - 8.30 am (includes breakfast)

Breakthroughs for new pain areas

This session will include outcome data from Nevro's Expanding Indications clinical study portfolio and the latest advances in HF10 Mechanism of Action.

Speaker: Jey Subbaroyan, Director of Nevro Clinical Research and Kerry Bradley, Sr. Director, Clinical Science & Research, Nevro